Balance Sheet
Cash Flow Statement
AmortizationCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Gains from Sales and Divestitures (2024)

Historic Gains from Sales and Divestitures for Avricore Health (AVCRF) over the last 1 years, with Q4 2024 value amounting to -$22930.8.

  • Avricore Health's Gains from Sales and Divestitures changed N/A to -$22930.8 in Q4 2024 from the same period last year, while for Dec 2024 it was -$22930.8, marking a year-over-year change of. This contributed to the annual value of -$23396.9 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Avricore Health reported Gains from Sales and Divestitures of -$22930.8 as of Q4 2024.
  • Over the past 5 years, Avricore Health's Gains from Sales and Divestitures peaked at -$22930.8 during Q4 2024, and registered a low of -$22930.8 during Q4 2024.